NorthSea Therapeutics B.V.
  • Home
  • About
  • Team
  • Presentations
  • Pipeline
  • News
  • Publications
  • Career
    • Job openings
  • Contact
Select Page

NorthSea Therapeutics secures €25 million funding for clinical development of promising NASH drug

12 Dec 2017 | News

Lead drug icosabutate, in-licensed from Pronova BioPharma AS Phase IIb-ready at the end of 2018 Naarden, The Netherlands, 12 December 2017 – NorthSea Therapeutics B.V. (‘NST’), a newly established Dutch biotech company, announced today the completion of a €25m Series...
Next Entries »

NorthSea Therapeutics

NorthSea Therapeutics is a clinical-stage biotech company developing first-in-class, oral, structurally engineered fatty acid therapeutics.

Contact

E: info@northseatherapeutics.com
T: +31 (0) 35 760 65 05

Address

Paasheuvelweg 25-C6
1105 BP Amsterdam
The Netherlands

© NorthSea Therapeutics B.V.